Molecular genetic testing has revealed pathogenic variants in GJB2 in about 20 % of NSHL patients and in STRC in 5–10 % of cases, particularly in children exhibiting high-frequency HL [2]. The gene discussed is GJB2; the disease is Hodgkins lymphoma.